w9j59We all need to be realistic. The current sp is reasonable in that there really has not been any earth shaken revenue generator. Share price in the real world is driven by revenue. All the increase in share price has been purely driven by expectation of the potential of Urocidin. I agree there is a great potential in Urocidin. But so far, it is still in Phase III and pre-approval stage. There is still a risk of failure of approval, though it is slim as I can see. All of us are hoping for the kind of buzz Dandeon got from the media and sp increase from this excitement. But bladder cancer is no prostate cancer nor colon cancer which everyone in the world knows somone in their circle has. It will never get the same media attention, especially pre-approval.
Without the revenue support, we are purely dreaming that the media and the investment world will share the same excitement of Urocidin as we have and somehow keep the sp up. This just ain't reasonable.
I agree with Been There though, that the greed of trying to accumulate a few more cheap shares to increase the trading position results in generating a low bidding market, which has help in this erosion of share price. Those of us who has a core holding has to remember why we have the core holding. It is an investment for the long term. It is an investment , not a specultion. So it will follow the normal eveluation mechanism. It will come when the revenue goes up with sales of Urocidin.
I would caution against the impulse to again generate too much expectation from the AUA's effect on the sp, lest it will cause another round of unreasonale disappointment and over-selling.
It is time for all of us to hunker down and wait with patience. It might be time for those that hold a trading position and a core position to mentally convert all into core holding. There is no short term profit to be taken. It will take time. Just don't sell and cause more artificial erosion of our sp. For all of our sakes.
GLTA